Building upon these previous findings, our study has made a novel observation in bladder cancer: we identified significantly elevated expression levels of TMBIM6 and ferroptosis-related proteins (GPX4, SLC7A11, and FTH1) in clinical bladder cancer specimens. This evidence concerns the gene TMBIM6 and urinary bladder carcinoma.